CDSCO UID MFG/IVD/2021/000073_b15aab46799c3fae1b16f09c3d5d39c9_8844a4691715dc6665319425dd08d416

SARS-CoV-2 Antibody Test

Diabetomics Medical (P) Ltd·Device Class Class C·India CDSCO·Brand: CovAbScreen / CovAb
Registration details
UID
MFG/IVD/2021/000073_b15aab46799c3fae1b16f09c3d5d39c9_8844a4691715dc6665319425dd08d416
Device class
Class C
Brand name
CovAbScreen / CovAb
Approving authority
CDSCO, Zonal office, Hyderabad
Product information
The CovAbScreenTM SARS-CoV-2 Ab Test is a lateral flow immunoassay intended for qualitative detection of total antibodies (CovAbScreen / CovAb) to SARS-CoV-2 in oral fluid specimen (CovAbScreen / CovAb)
Similar products (2)
Other products with the same name or brand
SARS-CoV-2 Antibody Test
Brand: Lateral Flow Method
Core Diagnostics Pvt. Ltd.
Class C
SARS-CoV-2 Antibody Test
Brand: Finecare
Matrix Labs
Class C
Other products from Diabetomics Medical (P) Ltd
Products from the same license holder (4 products)
C-Peptide Testing Kit
Brand: Lumella
Class B
Anticyclic Citrullinated Proteins Rapid Test
Brand: Lumella
Class B
Glutamic Acid Decarboxylase Test
Brand: Lumella
Class B
Preeclampsia Test System
Brand: Lumella
Class B
About this record

SARS-CoV-2 Antibody Test is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2021/000073_b15aab46799c3fae1b16f09c3d5d39c9_8844a4691715dc6665319425dd08d416. This device is marketed under the brand name CovAbScreen / CovAb. The license holder is Diabetomics Medical (P) Ltd, and it is classified as Device Class Class C. The approving authority is CDSCO, Zonal office, Hyderabad.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.